ASCO24 Updates: How PRIME-ROSE is Expanding Access to Precision Cancer Medicine

Kjetil Taskén, Head and Director of the Institute of Cancer Research at the Oslo University Hospital represents their submitted abstract at ASCO24. ‪@ous-hf‬

#oncodaily #asco2024 #cancerresearch #precisionmedicine #oncodailyasco24updates #asco24updates #oncology #cancer

SUBSCRIBE to get the latest #oncodaily    / @oncodailytv  

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn:   / oncodaily  
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram:   / oncodailynews  
Follow OncoDaily on TikTok:   / oncodaily  
Like OncoDaily on Facebook:   / oncodaily  

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”